Comparing HIIT and Moderate Exercise for Fatty Liver Outcomes

Metabolic dysfunction-associated steatotic liver disease (MASLD) has quietly become one of the most common chronic liver conditions in Australia. Recent estimates suggest it affects roughly one in three adults, with rates climbing alongside obesity, type 2 diabetes, and sedentary lifestyles that characterise post-pandemic routines in Brisbane, Sydney, and Perth. While weight loss through diet and physical activity remains the cornerstone of management, patients and clinicians continue to debate which exercise prescription delivers the greatest benefit in the shortest time.

The latest evidence comes from a randomised trial that placed head-to-head two very different training approaches: high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT). The study, conducted across several outpatient liver clinics, tracked changes in hepatic steatosis, liver enzymes, insulin resistance, and cardiorespiratory fitness over a 12-week supervised programme. Its findings are particularly relevant for Australians juggling long commutes, family responsibilities, and limited gym access.

What makes this trial notable is its pragmatic design. Participants were not elite athletes or paid volunteers; they were everyday patients with confirmed MASLD, many managing concurrent hypertension, dyslipidaemia, or prediabetes. By comparing protocols that mimic real-world gym or park sessions, the researchers offered practical guidance for primary care providers, exercise physiologists, and patients themselves.

Why Exercise Matters for Australians with Fatty Liver

Australia's National Health and Medical Research Council has long funded lifestyle interventions for chronic disease, yet uptake remains patchy. The Royal Australian College of General Practitioners recommends at least 150 minutes of moderate activity or 75 minutes of vigorous activity per week, but national surveys show fewer than half of adults meet these targets. For people with fatty liver, the gap is wider, partly because fatigue, joint discomfort, and time poverty discourage consistent participation.

The clinical stakes are significant. Untreated MASLD can progress to steatohepatitis, fibrosis, and eventually cirrhosis, placing patients on a trajectory toward liver transplantation, a costly and limited resource. Aboriginal and Torres Strait Islander communities, alongside people in regional Queensland and Western Australia, experience disproportionately higher rates of metabolic disease and face additional barriers to specialist care. Effective, scalable exercise programmes could ease pressure on overburdened liver clinics and tertiary hospitals.

Researchers at institutions such as the Princess Alexandra Hospital and the Translational Research Institute in Brisbane have been at the forefront of designing trials that reflect these realities. By embedding study sites within public health services, they ensure findings translate into the kind of care delivered through Medicare-funded chronic disease management plans, where exercise physiology referrals are partially rebated for eligible patients. Stakeholders keen to understand how such collaborations are assessed can review network evaluation methods used to gauge impact and reach.

Inside the Randomised Trial Design

Participants were randomly assigned to one of three groups: HIIT, moderate-intensity continuous training, or a stretching control. The HIIT protocol consisted of four 4-minute intervals at 85 to 95 percent of maximum heart rate, separated by active recovery, performed three times weekly. The moderate group walked or cycled at 60 to 70 percent of maximum heart rate for 45 minutes per session, also three times weekly. Sessions were supervised by accredited exercise physiologists, mirroring the qualifications required for Australian clinical practice.

Adherence was tracked through heart rate monitors and attendance logs. Researchers also collected blood samples for liver enzymes, HbA1c, and lipid panels, alongside MRI-derived proton density fat fraction measurements, the gold standard for non-invasive liver fat quantification. Quality-of-life questionnaires captured fatigue, mood, and self-reported energy levels.

Neither group was prescribed a specific diet, although participants were asked to maintain their usual eating patterns. This decision reflects the Australian reality where dietary advice is often inconsistent, influenced by multicultural food traditions ranging from Mediterranean-style meals in suburban Melbourne to high-carbohydrate takeaway habits documented in regional towns. By isolating the exercise variable, the trial offers a clearer signal about what movement alone can achieve.

Liver Fat and Enzyme Outcomes

After 12 weeks, both exercise groups showed meaningful reductions in hepatic steatosis compared with controls, but the HIIT group achieved a roughly 30 percent relative reduction in liver fat, compared with about 18 percent in the moderate group. These gains were measured by MRI-PDFF, an imaging technique increasingly available at major Australian radiology centres such as I-Med and Lumus Imaging.

Liver enzymes, including ALT and GGT, declined more sharply in the HIIT cohort, suggesting a stronger anti-inflammatory effect. Participants in the interval group also showed improved insulin sensitivity, with HOMA-IR scores dropping by approximately 25 percent. For clinicians managing patients with comorbid type 2 diabetes, a common pairing in Australian general practice, these metabolic shifts are clinically meaningful.

Cardiorespiratory fitness, measured by VO₂ max, improved more substantially in the HIIT arm, important given that poor aerobic capacity predicts cardiovascular mortality. While the Therapeutic Goods Administration does not regulate exercise as a therapy, mounting trial evidence is reshaping how peak bodies such as Exercise & Sports Science Australia view prescription intensity for chronic disease.

Adherence, Safety, and Accessibility

A common concern with HIIT is dropout. Shorter sessions sound appealing, but high-intensity efforts can feel punishing for deconditioned patients. Adherence rates were comparable between groups, hovering around 78 percent, with no serious adverse events reported. Minor musculoskeletal complaints were slightly more common in the HIIT arm, a reminder that screening for joint and cardiovascular conditions remains essential before prescribing vigorous activity.

Accessibility is a defining issue in Australia. Patients in outer suburban growth corridors like Springfield or Yatala travel significant distances to access allied health services, while those in Mount Isa or Broome rely on visiting specialists and telehealth. Supervised HIIT, delivered through Medicare-subsidised programs or community health hubs, could narrow these gaps.

Digital delivery also emerged as a viable adjunct. Many participants continued home-based sessions using wearable heart rate monitors, a model gaining traction through the Australian Digital Health Agency's investments in remote monitoring. For younger patients comfortable with technology and older patients supported by family, hybrid approaches may offer the best of both worlds.

Translating the Findings into Everyday Practice

For Australian clinicians, the trial supports a flexible, patient-centred approach. Some individuals thrive on the structure and time efficiency of intervals, completing a full session in under 25 minutes, ideal for shift workers in mining, hospitality, or healthcare who struggle to carve out longer windows. Others prefer the meditative rhythm of a long walk along Brisbane's riverwalk or a coastal path in Noosa.

Referral pathways matter. Exercise physiologists registered with the Australian Health Practitioner Regulation Agency can deliver both protocols safely, with services eligible for rebates under the Chronic Disease Management scheme. Discussions between GPs, dietitians, and patients should weigh personal preference, baseline fitness, and co-morbidities.

Beyond the clinic, public health messaging can shift. Campaigns that frame exercise as a powerful, evidence-based treatment for liver disease, rather than a vague wellness pursuit, may resonate with patients seeking tangible health outcomes. Workplace wellness programs in Brisbane and Parramatta's growing business district could incorporate short interval sessions during lunch breaks, supported by shower facilities and on-site trainers.

For Australians ready to take the next step, whether scheduling an exercise physiology referral through Medicare, joining a local walking group along the Brisbane River, or starting with short intervals at home, the path forward is more accessible than it once seemed. Clinicians and patients keen to explore ongoing trials, education, and partnership opportunities across Queensland can find practical resources at brisbanediamantina.com.